rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
11
|
pubmed:dateCreated |
2010-6-2
|
pubmed:grant |
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
1460-2105
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:day |
2
|
pubmed:volume |
102
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
747-9
|
pubmed:dateRevised |
2010-12-17
|
pubmed:meshHeading |
pubmed-meshheading:20463308-Animals,
pubmed-meshheading:20463308-Antineoplastic Agents,
pubmed-meshheading:20463308-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:20463308-Apoptosis,
pubmed-meshheading:20463308-Cell Survival,
pubmed-meshheading:20463308-Clinical Trials as Topic,
pubmed-meshheading:20463308-Disease Models, Animal,
pubmed-meshheading:20463308-Growth Inhibitors,
pubmed-meshheading:20463308-Humans,
pubmed-meshheading:20463308-Mice,
pubmed-meshheading:20463308-Neuroblastoma,
pubmed-meshheading:20463308-Phosphorylcholine,
pubmed-meshheading:20463308-Proto-Oncogene Proteins c-akt,
pubmed-meshheading:20463308-Receptor Protein-Tyrosine Kinases,
pubmed-meshheading:20463308-Transplantation, Heterologous
|
pubmed:year |
2010
|
pubmed:articleTitle |
Getting into the AKT.
|
pubmed:publicationType |
Editorial,
Comment
|